VAV2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62525548574877E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.1251000958955E-10 |
Normal-vs-Stage2 |
3.18030000001635E-07 |
Normal-vs-Stage3 |
<1E-12 |
Normal-vs-Stage4 |
5.17363929475323E-14 |
Stage1-vs-Stage2 |
1.977200E-01 |
Stage1-vs-Stage3 |
1.71382999999414E-05 |
Stage1-vs-Stage4 |
9.015500E-04 |
Stage2-vs-Stage3 |
2.387800E-01 |
Stage2-vs-Stage4 |
3.551600E-01 |
Stage3-vs-Stage4 |
7.680000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62447832963153E-12 |
Normal-vs-AfricanAmerican |
1.457580E-03 |
Normal-vs-Asian |
1.603170E-01 |
Caucasian-vs-AfricanAmerican |
7.805900E-04 |
Caucasian-vs-Asian |
8.271600E-02 |
AfricanAmerican-vs-Asian |
7.461600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.11022302462516E-16 |
Normal-vs-Female |
4.86399998056442E-09 |
Male-vs-Female |
3.90799999999691E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.38329999999076E-06 |
Normal-vs-Age(41-60Yrs) |
3.05311331771918E-14 |
Normal-vs-Age(61-80Yrs) |
1.63291602461868E-12 |
Normal-vs-Age(81-100Yrs) |
2.804000E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.740000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.838800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.755600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.749800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.152000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.318000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
7.134200E-01 |
Normal-vs-Grade 2 |
2.95009572326421E-11 |
Normal-vs-Grade 3 |
1.62447832963153E-12 |
Normal-vs-Grade 4 |
1.00452979268084E-12 |
Grade 1-vs-Grade 2 |
4.058700E-03 |
Grade 1-vs-Grade 3 |
1.86129999999451E-05 |
Grade 1-vs-Grade 4 |
4.599600E-04 |
Grade 2-vs-Grade 3 |
2.449700E-04 |
Grade 2-vs-Grade 4 |
6.500700E-03 |
Grade 3-vs-Grade 4 |
8.343800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.3347990207867E-12 |
Normal-vs-ccB subtype |
1.11022302462516E-15 |
ccA subtype-vs-ccB subtype |
2.551800E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.62492241884138E-12 |
Normal-vs-N1 |
2.367500E-02 |
N0-vs-N1 |
3.374600E-01 |
|
|